News and Announcements
Folkestone Distribution Reinvestment Plan
- Published March 23, 2016 2:32PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
23rd March 2016
In accordance with the 2016 full year distribution guidance of 13.4 cents per unit (cpu), Folkestone Investment Management Limited as the responsible entity of the Folkestone Education Trust (FET) gives notice that the distribution for the quarter ending 31 March 2016 is 3.35 cpu.
The Distribution Reinvestment Plan (DRP) will apply to this distribution with a discount of 1.5% to the average of the daily volume weighted average market price recorded on the ASX commencing on 4 April 2016 through to 15 April 2016. Unitholders who have not yet participated in the DRP are required to complete and sign their application form and return it to FET’s registry, Boardroom Pty Limited by 4 April 2016 to participate in this quarter’s DRP.
To view the full article please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
